Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10535697 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Conditions: Asthma;   Bronchospasm;   Wheezing;   Shortness of Breath
Interventions: Drug: Epinephrine Inhalation Aerosol, HFA;   Drug: Epinephrine Inhalation Aerosol
2 Terminated Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Condition: Asthma
Interventions: Drug: Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation;   Drug: Arm C-Epinephrine Inhalation Aerosol CFC
3 Completed Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS
Condition: Asthma
Interventions: Drug: Treatment arm T1;   Drug: Treatment arm T2;   Drug: Treatment arm C

Indicates status has not been verified in more than two years